Collection and Preservation of Cord Blood for Personal Use


      Unrelated-donor umbilical cord blood (CB) is a useful alternative hematopoietic stem cell source for patients without suitably matched and readily available related or unrelated stem cell donors. Expectant parents today may have the option of either donating the CB to a public CB bank or keeping and storing the CB in a private bank for potential use in the future. The alternatives are often referred to as public banking and private banking. On behalf of the American Society of Blood and Marrow Transplantation (ASBMT), we have reviewed the currently available data and opinions and offer the following recommendations:
      • 1.
        Public donation of CB is encouraged where possible.
      • 2.
        The probability of using one's own CB is very small—difficult to quantify but probably as low as 0.04% (1:2500) to 0.0005% (1:200,000) in the first 20 years of life—and therefore, storage of CB for personal use is not recommended.
      • 3.
        Family member banking (collecting and storing CB for a family member) is recommended when there is a sibling with a disease that may be treated successfully with allogeneic transplant. Family member banking on behalf of a parent with a disease that may be treated successfully with allogeneic transplant is only recommended when there are shared HLA-antigens between the parents.
      The committee acknowledges the expanding potential of indications for CB in the future, and suggests review of these recommendations at regular intervals.

      Key Words


        • Brunstein C.G.
        • Setubal D.C.
        • Wagner J.E.
        Expanding the role of umbilical cord blood transplantation.
        Br J Haematol. 2007; 137: 20-35
        • Gluckman E.
        • Rocha V.
        Donor selection for unrelated cord blood transplants.
        Curr Opin Immunol. 2006; 18: 565-570
        • Barker J.N.
        • Weisdorf D.J.
        • DeFor T.E.
        • et al.
        Transplantation of two partially HLA-matched umbilical cord blood units to enhance engraftment in adults with hematologic malignancy.
        Blood. 2005; 105: 1343-1347
        • Ballen K.K.
        • Spitzer T.R.
        • Yeap B.Y.
        • et al.
        Double unrelated reduced-intensity umbilical cord blood transplantation in adults.
        Biol Blood Marrow Transplant. 2007; 13: 82-89
        • Eapen M.
        Outcomes of transplantation of unrelated donor umbilical cord blood and bone marrow in children with acute leukemia: a comparison study.
        Lancet. 2007; 369: 1947-1954
        • Laughlin M.J.
        • Eapen M.
        • Rubinstein P.
        • et al.
        Outcomes after transplantation of cord blood or bone marrow from unrelated donors in adults with leukemia.
        N Engl J Med. 2004; 351: 2265-2275
        • Rocha V.
        • Labopin M.
        • Sanz G.
        • et al.
        Transplants of umbilical-cord blood or bone marrow from unrelated donors in adults with acute leukemia.
        N Engl J Med. 2004; 351: 2276-2285
        • Barker J.N.
        • Weisdorf D.J.
        • DeFor T.E.
        • Blazar B.R.
        • Miller J.S.
        • Wagner J.E.
        Rapid and complete donor chimerism in adult recipients of unrelated donor umbilical cord blood transplantation after reduced-intensity conditioning.
        Blood. 2003; 102: 1915-1919
        • Beam D.
        • Poe M.D.
        • Provenzale J.M.
        • et al.
        Outcomes of unrelated cord blood transplantation for X-linked adrenoleukodystrophy.
        Biol Blood Marrow Transplant. 2007; 13: 665-674
        • Escobar M.L.
        • Poe M.D.
        • Provenzale J.M.
        • et al.
        Transplantation of umbilical cord blood in babies with infantile Krabbe's disease.
        N Engl J Med. 2005; 352: 2069-2081
        • Lasky L.C.
        • Lane T.
        • Miller J.
        • et al.
        In utero or ex utero cord blood collection: which is better?.
        Transfusion. 2002; 42: 1261-1267
        • Wang B.
        • Tsukahara E.
        • Wu T.
        • et al.
        Comparison of cell dose and outcome for CB transplantation sourced from plasma depleted versus red cell depleted CB inventories.
        Biol Blood Marrow Transplant. 2007; 13: 113a
        • Locatelli F.
        • Rocha V.
        • Reed W.
        • et al.
        Related umbilical cord blood transplantation in patients with thalassemia and sickle cell disease.
        Blood. 2003; 101: 2137-2143
        • Walters M.C.
        • Quirolo L.
        • Edwards S.
        • et al.
        Directed donor CB transplantation for hematologic disorders.
        Biol Blood Marrow Transplant. 2007; 13: 79a
        • Walters M.C.
        • Quirolo L.
        • Trachtenberg E.T.
        • et al.
        Sibling donor CB transplantation for thalassemia major: experience of the Sibling Donor Cord Blood Program.
        Ann N Y Acad Sci. 2005; 1054: 206-213
      1. Phone conversations between Susan Stewart and Community Blood Services, The Genesis Bank, Family Cord Blood Services, Cord Blood Registry, Cryobanks International, Cryo-Cell International, Domani Cell, Lifebank USA, Lifeline Cryogenics, MAZE Labs, StemCyte Family, and Viacord.

        • Ferreria E.
        • Pasternak J.
        • Bacal N.
        • et al.
        Autologous cord blood transplantation.
        Bone Marrow Transplant. 1999; 24: 1041
        • Fruchtman S.M.
        • Hurlet A.
        • Dracker R.
        • et al.
        The successful treatment of severe aplastic anemia with autologous cord blood transplantation.
        Biol Blood Marrow Transplant. 2004; 10: 741-742
        • Rosenthal J.
        • Bolotin E.
        • Pawlowska A.
        • et al.
        Hematopoietic stem cell transplantation with autologous cord blood units in two patients with severe aplastic anemia: time for reassessment?.
        Biol Blood Marrow Transplant. 2007; 13: 100a
        • Hayani A.
        • Lampeter E.
        • Viswanatha D.
        • et al.
        First report of autologous cord blood transplantation in the treatment of a child with leukemia.
        Pediatrics. 2007; 119: 296-300
        • Viener H.L.
        • Brusko T.
        • Wasserfall C.
        • et al.
        Changes in regulatory T cells following autologous umbilical cord blood transfusion in children with type I diabetes.
        J Am Diabetes Assoc. 2007; (0314 (abstract))
        • Johnson F.L.
        Placental blood transplantation and autologous banking-caveat emptor.
        J Pediatr Heme Oncol. 1997; 19: 183-186
        • Annas G.J.
        Waste and longing—the legal status of placental blood banking.
        N Engl J Med. 1999; 34: 1521-1524
        • Ecker J.L.
        • Greene M.F.
        The case against private umbilical cord blood banking.
        Obstet Gynecol. 2005; 105: 1-2
        • Greene M.F.
        • Cefalo R.C.
        Obstetricians' perspectives on umbilical cord blood storage.
        Cancer Res Ther Control. 1999; 8: 341-343
        • Burgio G.R.
        • Gluckman E.
        • Locatelli F.
        • et al.
        Ethical reappraisal of 15 years of cord blood transplantation.
        Lancet. 2003; 361: 250-252
        • Gale K.B.
        Backtracking leukemia to birth: identification of clonotypic gene fusion sequences in neonatal blood spots.
        Proc Natl Acad Sci USA. 1997; 94: 13950-13954
        • Koylka P.
        • Ivanyi P.
        • Bruer-Vriesendorp B.S.
        Preservation of immunological and colony-forming capacities of long-term (15 years) cryopreserved cord blood cells.
        Transplantation. 1998; 65: 1275-1278
        • Broxmeyer H.E.
        • Srour E.F.
        • Hangoc G.
        • et al.
        High-efficiency recovery of functional hematopoietic progenitor and stem cells from human cord blood cryopreserved for 15 years.
        Proc Natl Acad USA. 2003; 100: 645-650
        • Newcomb J.D.
        • Sanberg P.R.
        • Klasko S.K.
        • Willing A.F.
        Umbilical cord blood research: current and future perspectives.
        Cell Transplant. 2007; 16: 151-158
        • Goodwin H.S.
        • Bicknese A.R.
        • Chien S.N.
        • Bogucki B.D.
        • Quinn C.O.
        • Wall D.A.
        Multilineage differentiation activity by cells isolated from umbilical cord blood: expression of bone, fat, and neural markers.
        Biol Blood Marrow Transplant. 2001; 7: 581-588
        • Korbling M.
        • Robinson S.
        • Estrov Z.
        • Champlin R.
        • Shpall E.
        Umbilical cord blood-derived cells for tissue repair.
        Cytotherapy. 2005; 7: 258-261
        • Goldberg J.L.
        • Laughlin M.J.
        Umbilical cord blood hematopoeitic stem cells and therapeutic angiogenesis.
        Cytotherapy. 2007; 9: 4-13
      2. American Academy of Pediatrics Section on Hematology/Oncology: Cord Blood Banking for Potential Future Transplantation.
        Pediatrics. 2007; 119: 165-170
        • American College of Obstetricians and Gynecologists
        Routine storage of umbilical cord blood for potential future transplantation.
        ACOG Committee Opin. 1997; 183: 1-3
        • Katiz-Benichou G.
        Umbilical cord blood banking: economic and therapeutic challenges.
        Int J Healthcare Technol. Manage. 2007; 8: 464-477
      3. European Group on Ethics in Science and New Technologies. Ethical aspects of umbilical cord blood banking. December 16, 2005.

      Linked Article

      • On the Probability of Using Cord Blood
        Biology of Blood and Marrow TransplantationVol. 14Issue 6
        • In Brief
          The ASBMT Position Statement on Collection and Preservation of Cord Blood for Personal Use and the underlying ASBMT Committee Report [1,2] were recently published in BBMT. These documents give the likelihood of autologous use of a stored cord blood (CB) unit as between 0.04% and 0.0005% (without specifying the age of the recipient), citing several papers as sources for these estimates [3-7]. This is a very wide range, and review of the citations does not reveal the origin of the lower probability.
        • Full-Text
        • PDF
        Open Archive